Investor insights
Sectors invested in
Funding rounds participated in
$21M sweet spot round size
Most of their 24 investments are in rounds between $8.6M and $42M
Investor type
Basic info
Industry
Sectors
Date founded
2015
Investments made
dualyx raised $44M on May 15, 2023
Investors: KU Leuven Innovation & Entrepreneurship, Andera Partners, Forbion, High-Tech Gründerfonds, BGV (BioGeneration Ventures), VIB and V-Bio Ventures
Sibylla Biotech raised $23M on October 4, 2022
Investors: 3B Future Health Fund, VI Partners AG, Indaco Venture Partners, Seroba-Kernel Ltd (Ireland), Claris Ventures SGR SpA and V-Bio Ventures
AstriVax raised $30M on August 25, 2022
Investors: KU Leuven Innovation & Entrepreneurship, Merieux Equity Partners, Ackermans & van Haaren, Thuja Capital, BNP Paribas Fortis, FundPlus and V-Bio Ventures
Precirix raised $88M on March 16, 2022
Investors: Gimv, Pontifax Venture Capital, Inkef, HealthCap, Novo Holdings, BioMedPartners, Forbion and V-Bio Ventures
Corteria Pharmaceuticals raised $14M on December 9, 2021
Investors: Omnes and V-Bio Ventures
Muna Therapeutics raised $73M on July 9, 2021
Investors: Sanofi Ventures, Sofinnova Partners, VIB, Novo Holdings, LSP (Life Sciences Partners), Polaris Partners and V-Bio Ventures
Aphea.Bio raised $22M on April 14, 2021
Investors: KU Leuven Innovation & Entrepreneurship, Vives Louvain Technology Fund, European Circular Bioeconomy Fund, VIB and V-Bio Ventures
Protealis raised $14M on April 8, 2021
Investors: V-Bio Ventures
Agomab Therapeutics raised $74M on March 10, 2021
Investors: Omnes, Redmile Group, Pontifax Venture Capital, AdBio partners, Andera Partners and V-Bio Ventures
Oxular raised $37M on March 1, 2021
Investors: IP Group plc, Forbion and V-Bio Ventures